Burton Kendall Wasson

This inventor holds 8 USPTO granted patents. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc.. Active years: 1976-1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Burton Kendall Wasson. Retrieved from https://idiyas.com/inventor/burton-kendall-wasson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 58(Granted Patents)

Location History:

Valois, CA (1976 - 1982)
Ingleside, CA (1982)

Company Filing History:

6 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 1976-1982

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4348398 - Quinolinyl ethanolamines (1982-09-07),

2. 4343802 - 2-(3-Substituted amino-2-hydroxypropoxy)-3-piperidino pyrazines for use (1982-08-10),

3. 4193995 - 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazine (1980-03-18),

4. 4042586 - 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines (1977-08-16),

5. 4011217 - 4-(3-Amino-2-acyloxypropoxy)-1,2,5-thiadiazole compounds (1977-03-08),

6. 3993656 - 1,8-Naphthyridine compounds (1976-11-23),

7. 3946009 - 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines (1976-03-23),

8. 3944560 - 3-Hydroxy-3-(1,2,5-thiadiazolyloxyalkanol)-3,4-dihydro-2H-1,5-ben (1976-03-16),

Title: Burton Kendall Wasson: A Pioneer in Heterocyclic Chemistry

Introduction

Burton Kendall Wasson, an innovative inventor based in Valois, CA, has made significant contributions to the field of heterocyclic chemistry. With a portfolio of eight patents to his name, Wasson has focused his research on developing compounds with potential therapeutic applications, particularly in the realm of adrenergic blocking properties.

Latest Patents

Wasson's latest patents include groundbreaking work on quinolinyl ethanolamines and heterocyclic ethanolamines. One notable patent describes compounds of the formula 2-(3-Substituted amino-2-hydroxypropoxy)-3-piperidino pyrazines, which are designed for use as 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazine compounds. These compounds may contain substituents in the 5 and/or 6 positions, showcasing their potential for β-adrenergic blocking properties. The inventive process involves the reaction of a 2-chloro (or hydroxy) pyrazine with a 5-hydroxymethyl (or sulfonyloxymethyl) oxazolidine, followed by acid hydrolysis, highlighting the intricate chemical processes that underpin his inventions.

Career Highlights

Throughout his distinguished career, Burton Kendall Wasson has worked with prominent companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His tenure at these institutions has provided him with invaluable experience and a platform to pursue his research ambitions.

Collaborations

Wasson has collaborated with esteemed colleagues in the field, such as Leonard M. Weinstock and Haydn W. Williams. These collaborations have facilitated the sharing of ideas and knowledge, further driving innovation in their area of expertise.

Conclusion

Burton Kendall Wasson's dedication to innovation in the realm of heterocyclic compounds has led to significant advancements that may impact pharmaceutical applications. His work exemplifies the spirit of invention and collaboration that is essential for progress in science and technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]